Cisplatin-associated ototoxicity amongst cervical cancer patients: A prospective cohort study in south Africa.
Jessica PakenCyril Devadas GovenderMershen PillayMerga FeyasaVikash SewramPublished in: PloS one (2023)
The findings of this epidemiologic study highlight the temporal course and severity of ototoxicity experienced by cervical cancer patients treated with cisplatin, with greater impact in HIV-positive subgroup, thus underscores the need for audiological monitoring and timely interventions in this cohort.